Simultaneous spectrophotometric estimation of atorvastatin calcium and amlodipine besylate in tablet dosage forms

International Journal of ChemTech Research

Volumn 2, Issue 1, 2010, Pages 633-639

  Chaudhari, Bharat G ^a   Patel, Ashok B ^b  

^a GANPAT UNIVERSITY   (India)

^b AR Patel and GH Patel Institute of Pharmacy   (India)

Author keywords

Amlodipine besylate; Atorvastatin calcium; Spectrophotometric

Indexed keywords

AMLODIPINE BESYLATE; ATORVASTATIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; DRUG DOSAGE FORM; ECONOMIC EVALUATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SPECTROPHOTOMETRY; TABLET FORMULATION;

EID: 77953370941     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Witzum J.L., "Drugs used in the treatment of hyperlipoproteinemias, " ed. by Hardman J. G., Limbird L. E., Molonoff P. B., 9th Edn., McGraw-Hill, New York, 1996, 875-897.
2. Walsh P., "Physician Desk Reference," 5th ed., Medical Economics Company Inc., Montvale, NJ, 2000, p. 2358-2360.
3. Report on combination therapy of atorvastatin and amlodipine for combined dyslipidemia and hypertension. Pfizer Labs, division of Pfizer, Inc., NY, October 2004.
4. Budavari, S., The Merck Index, an Encyclopedia of Chemicals, Drugs, and Biologicals, Merck & Co. Inc., Whitehouse Station, 13th Edn, NJ, 2001, 148.
5. Budavari, S., The Merck Index, an Encyclopedia of Chemicals, Drugs, and Biologicals, Merck & Co. Inc., Whitehouse Station, NJ, 13th Edn, 2001, 86-87.
6. Indian Pharmacopoeia, Govt. of India, Ministry of Health and Family Welfare, Vol. 2, Delhi: Publication by Controller of Publication, 2007, 749-52.
7. Indian Pharmcopoeia, Govt. of India, Ministry of Health and Family Welfare, Vol. 2, Delhi: Publication by Controller of Publication, 2007, 714-16.
8. British Pharmacopoeia, International ed. Published on the Recommendation of the Medicines Comissions Pursuant to Medicines Act vol. 1, 2005, 138.
9. The European Pharmacopoeia, Counsile of Europe, Codex,France, 4th Edn, 2002, 639-40.
10. The United States Pharmacopoeia Convention, Inc., Rockville, MD, 2007, 3496-97, 1532.
11. Zarghi A., Shafaati A., Foroutan S.M. and Khoddam A., A simple and rapid HPLC method for the determination of atorvastatin in human plasma with UV detection and its application to pharmacokinetic studies, Arzneimittelforschung. , 2005, 55, 451-454.
12. Koytchev R., Ozalp Y., Erenmemisoglu A., VanderMeer M.J. and Alpan R.S., Bioequivalence study of atorvastatin tablets, Arzneimittelforschung., 2004, 54, 573-577.
13. Bahrami G., Mohammadi B., Mirzaeei S. and Kiani A., Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection, J. Chromatogra. B, 2005, 826, 41-45.
14. Hermann M., Christensen H., and Reubsaet J.L., Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS, Anal. Bioanal. Chem., 2005, 382, 1242-1249.
15. Jemal M., Ouyang Z., Chen B.C., and Teitz D., Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometry, Rapid Commun. Mass Spectrom., 1999, 13, 1003-1015.
16. Bullen W.W. and Miller R.A., Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma, J. Am. Soc. Mass Spectrom., 1999, 10, 55-66.
17. Erturk S., Sevinc A.E., Ersoy L. and Ficicioglu S., An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets, J. Pharm. Biomed. Anal., 2003, 33, 1017-1023.
18. Pasha M.K., Muzeeb S., Basha S.J., Shashikumar D., Mullangi R. and Srinivas N. R., Analysis of five HMG-CoA reductase inhibitors- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies, Biomed. Chromatogr., 2006, 20, 282-293.
19. Manoj K., Shanmugapandiyan P. and Anbazhagan S., RP-HPLC method for simultaneous estimation of atorvastatin and aspirin from capsule formulation, Indian Drugs, 2004, 41, 284-288.
20. Yadav S.S., Mhaske D.V., Kakad A.B., Patil B.D., Kadam S.S. and Dhaneshwar S. R., A simple and sensitive HPTLC method for the determination of content uniformity of atorvastatin calcium tablets, Indian J. Pharm. Sci., 2005, 67, 182-186.
21. Khopde S.A. and Jain N.K., Difference spectrophotometric estimation of amlodipine besylate, Indian Drugs, 2000, 37, 351-53.
22. Bahrami G. and Mirzaeei S., Simple and rapid HPLC method for determination of amlodipine in human serum with fluorescence detection and its use in pharmacokinetic studies, J. Pharm. Biomed. Anal., 2004, 36, 163-68.
23. Streel B., Laine C., Zimmer C., Sibenaler R. and Ceccato A., Enantiomeric determination of amlodipine in human plasma by liquid chromatography coupled to tandem mass spectrometry, J. Biochem. Biophys. Methods., 2002, 54, 357-68.
24. Carvalho M., Oliveira C.H., Mendes G.D., Sucupira M., Moraes M.E. and De Nucci G., Amlodipine bioequivalence study: quantification by liquid chromatography coupled to tandem mass spectrometry, Biopharm. Drug. Dispos., 2001, 22, 383-90.
25. Patki R.V., Tamhankar C.P. and Tipnis H.P., Simple and rapid high performance liquid chromatographic estimation of amlodipine from pharmaceutical dosage, Indian Drugs, 1994, 31, 560-61.
26. Avadhanulu A.B., Srinivas J.S. and Anjaneyulu Y., RP-HPLC determination of amlodipine besylate in drug and its pharmaceutical dosage forms, Indian Drugs, 1996, 33, 36-40.
27. Zarapkar S.S., Katle S.S. and Rane S.H., HPLC determination of amlodipine and atenolol simultaneously from pharmaceutical preparation, Indian Drugs, 1997, 34, 350-53.
28. Valiyare G.R., Chandra A., Apte S.K. and Mahadik A.A., HPLC determination of amlodipine, losartan and ramipril in pharmaceutical formulations, Indian Drugs, 2005, 42, 309-312.
29. Kamble N. and Venkatachalam A., Determination and validation of HPLC method for simultaneous determination of lisinopril and amlodipine from tablet, Indian Drugs, 2004, 41, 179-781.
30. Kulkarni A.P., Gat G.V., Pimple S.V. and Joshi M.A., HPLC method for determination of losartan potassium and amlodipine besylate in tablets, Indian Drugs, 2003, 40, 298-299.
31. Zarapkar S.S. and Kanyawar N. S., Simultaneous estimation of amlodipine besylate and losartan potassium in pharmaceutical dosage by RP-HPLC, Indian Drugs, 2002, 39, 338-41.
32. Altiokka G. and Altiokka M., Flow injection analysis of amlodipine using UV-detection, Pharmazie., 2002, 57, 500-503.
33. Pandya K.K., Satia M., Gandhi T.P. and Modi I. A., Detection and determination of total amlodipine by high-performance thin-layer chromatography: a useful technique for pharmacokinetic studies, J. Chromatogr. B, 1995, 667, 315-320.
34. Kamat K., Chaturvedi S.C., Stability indicating assay method for amlodipine tablets, Indian J. Pharm. Sci., 2005, 67, 236-239.
35. Naidu K.K., Kale U.N., Shingare M.S., Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product J. Pharm. Biomed. Anal., 2005, 39, 147-155.
36. Sahu R. and Patel V.B., Simultaneous spectrophotometric determination of amlodipine besylate and atorvastatin calcium from their binary mixture by dual wavelength and zero absorbance measurement, Indian Drugs, 2006, 43, 160-161.
37. Chaudhari B.G. and Patel N.M., Development and Validation of HPLC method for simultaneous estimation of Atorvastatin Calcium and Amlodipine Besylate, J. Pharm. Research, 2006, 5, 141-144.
38. Chaudhari B.G., Patel N.M. and Shah P.B., Stability Indicating RP-HPLC for simultaneous determination of atorvastatin calcium and amlodipine besylate from their combination drug Products, Chem. Pharm. Bull., 2007, 55, 241-246.
39. Chaudhari, B.G, Patel, N. M. and Shah, P. B., Simultaneous estimation of atorvastatin and amlodipine from formulation by HPTLC. Indian Drugs, 2006, 43, 649-655.
40. Shishoo C.J., Shah S.A., Rathod, I.S., Savle S.S., Kotecha J.S. and Shah P.B., Int. J. Pharm., 1999, 190, 109.
41. nd Edn., The Pharmaceutical Press, London, 1986, 229.